Amino acids, ammonia, and hepatic encephalopathy.


Journal

Analytical biochemistry
ISSN: 1096-0309
Titre abrégé: Anal Biochem
Pays: United States
ID NLM: 0370535

Informations de publication

Date de publication:
15 07 2022
Historique:
received: 15 09 2021
revised: 30 03 2022
accepted: 21 04 2022
pubmed: 3 5 2022
medline: 25 5 2022
entrez: 2 5 2022
Statut: ppublish

Résumé

Hepatic encephalopathy (HE) is a decline in brain function arising due to liver insufficiency. The liver's diminished capacity to clear ammonia, and the subsequent accumulation of it, is highly implicated in pathogenesis of HE. Ammonia is endogenously generated from the catabolism of amino acids derived from dietary protein intake. Therefore, a conflict arises in cirrhosis where dietary protein intake may increase ammonia and precipitate HE, and at the same time, cirrhotic patients require high daily protein intake due to altered nutrient metabolism. A nutritional solution is needed to deliver sufficient doses of protein to patients without increasing the risk of HE. In order to address this issue, this review will discuss the catabolism of individual amino acids with a special focus on ammonia-generating steps and highlight a subset of amino acids that have the potential to generate multiple equivalents of ammonia. Following, studies investigating the effects of individual amino acids in cirrhosis on blood ammonia levels as well as development of HE will be reviewed.

Identifiants

pubmed: 35500655
pii: S0003-2697(22)00152-X
doi: 10.1016/j.ab.2022.114696
pii:
doi:

Substances chimiques

Amino Acids 0
Dietary Proteins 0
Ammonia 7664-41-7

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

114696

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Katerina Kroupina (K)

Université de Montréal, Département de Médicine, 2900 Edouard Montpetit Blvd, Montréal, Québec, H3T 1J4, Canada; Laboratoire Hépato-Neuro, Centre de recherche du Centre Hospitalier de l'Université de Montréal, 900 Saint Denis St, Montréal, Québec, H2X 0A9, Canada.

Chantal Bémeur (C)

Laboratoire Hépato-Neuro, Centre de recherche du Centre Hospitalier de l'Université de Montréal, 900 Saint Denis St, Montréal, Québec, H2X 0A9, Canada; Université de Montréal, Département de Nutrition, 2405 chemin de la Côte-Sainte-Catherine, Montréal, Québec, H3T 1A8, Canada.

Christopher F Rose (CF)

Université de Montréal, Département de Médicine, 2900 Edouard Montpetit Blvd, Montréal, Québec, H3T 1J4, Canada; Laboratoire Hépato-Neuro, Centre de recherche du Centre Hospitalier de l'Université de Montréal, 900 Saint Denis St, Montréal, Québec, H2X 0A9, Canada. Electronic address: christopher.rose@umontreal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH